ProShares - Ultra FTSE China 50

ProShares - Ultra FTSE China 50

XPP
ProShares - Ultra FTSE China 50US flagNew York Stock Exchange Arca
- -
USD
- -
- -
- -
- -
(- -)

Recent

price

- -

P/E

ratio

- -

div

yld

- -

ROIC.AI

No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available
Business
ProShares Ultra FTSE China 50 (XPP) is a leveraged exchange-traded fund that seeks daily investment results, before fees and expenses, that correspond to two times (2x) the daily performance of the FTSE China 50 Index. The fund provides amplified exposure to large-cap Chinese equities listed on the Hong Kong Stock Exchange, including major companies such as Tencent Holdings, Alibaba Group, Meituan, and China Construction Bank; it employs financial derivatives including swap agreements, futures contracts, and exchange-traded funds tracking the benchmark index to achieve its leverage objective. XPP targets sophisticated investors seeking short-term trading opportunities in the Chinese equity market, with primary operations in the United States serving global institutional and retail clients through major brokerage platforms. Launched in 2007 by ProShare Advisors LLC, a subsidiary of ProFunds Group headquartered in Bethesda, Maryland, the fund operates within the broader exchange-traded product industry, focusing on the Asia-Pacific emerging markets segment. It offers daily leveraged performance without direct investment in underlying securities, mitigating some operational risks associated with physical replication while exposing investors to heightened volatility and potential compounding effects over holding periods exceeding one day. In recent developments as of late 2025, ProShares has expanded its suite of China-focused leveraged products amid renewed interest in A-share access following U.S.-China trade thaw initiatives, including the launch of enhanced inverse and ultra-inverse variants tied to FTSE indices; the firm also announced strategic partnerships with key index providers to refine tracking methodologies amid regulatory shifts in Hong Kong listings. No major acquisitions or funding rounds specific to XPP have been reported in the last two years, though ProShares as a whole underwent operational enhancements to improve liquidity provision during periods of market stress in Chinese equities.